David M Orenstein1, Linda W Higgins. 1. School of Medicine and bSchool of Nursing, Children's Hospital of Pittsburgh and University of Pittsburgh, Pittsburgh, Pennsylvania 15213-2583, USA. davido@pitt.edu
Abstract
PURPOSE OF REVIEW: The role of exercise in patients with cystic fibrosis has been recognized for as long as cystic fibrosis has been identified as a clinical syndrome, as exercise intolerance has always been a hallmark of disease progression. RECENT FINDINGS: Work published in the past year has shed new light on several aspects of this field, including physiologic responses to exercise, responses to exercise programs, and the epidemiologic and prognostic implications of activity and exercise testing. SUMMARY: Barker's work is perhaps the most compelling, as it highlights the overwhelming interest and belief in the utility of exercise testing and prescription among cystic fibrosis physicians and the contrasting paucity of programs that test their patients and prescribe exercise for them. More studies are needed to identify the form of exercise programs and tests that are most likely to be effective and to be used by cystic fibrosis centers and patients.
PURPOSE OF REVIEW: The role of exercise in patients with cystic fibrosis has been recognized for as long as cystic fibrosis has been identified as a clinical syndrome, as exercise intolerance has always been a hallmark of disease progression. RECENT FINDINGS: Work published in the past year has shed new light on several aspects of this field, including physiologic responses to exercise, responses to exercise programs, and the epidemiologic and prognostic implications of activity and exercise testing. SUMMARY: Barker's work is perhaps the most compelling, as it highlights the overwhelming interest and belief in the utility of exercise testing and prescription among cystic fibrosis physicians and the contrasting paucity of programs that test their patients and prescribe exercise for them. More studies are needed to identify the form of exercise programs and tests that are most likely to be effective and to be used by cystic fibrosis centers and patients.
Authors: Stephen E Kirkby; Don Hayes; Jonathan P Parsons; Clayton E Wisely; Ben Kopp; Karen S McCoy; John G Mastronarde Journal: Lung Date: 2015-06-03 Impact factor: 2.584
Authors: Bradley S Quon; Donald L Patrick; Todd C Edwards; Moira L Aitken; Ronald L Gibson; Alan Genatossio; Sharon McNamara; Christopher H Goss Journal: J Cyst Fibros Date: 2012-01-04 Impact factor: 5.482
Authors: Kaitlin O'Keefe; Rhonda Orr; Peite Huang; Hiran Selvadurai; Peter Cooper; Craig Frank Munns; Maria A Fiatarone Singh Journal: J Clin Med Res Date: 2013-04-23
Authors: Owen W Tomlinson; Alan R Barker; Lucy V Chubbock; Daniel Stevens; Zoe L Saynor; Patrick J Oades; Craig A Williams Journal: Eur J Appl Physiol Date: 2018-07-12 Impact factor: 3.078